Literature DB >> 6695353

Jaundice after open heart surgery: a prospective study.

C M Chu, C H Chang, Y F Liaw, M J Hsieh.   

Abstract

One hundred and fifty four consecutive adult patients having cardiac surgery for a variety of cardiac lesions were evaluated prospectively for postoperative jaundice, those with a raised preoperative serum bilirubin concentration (greater than 34 mumol/l or 2 mg/100 ml) being excluded. The incidence of early postoperative jaundice, as defined by a serum bilirubin concentration of 50 mumol/l (3.0 mg/100 ml) or greater, was 23.4%. The jaundice was mild (bilirubin concentration 51-100 mumol/l (3.0-6.0 mg/100 ml] in 26 patients (16.9%) and moderate to severe (greater than 100 mumol/l (6.0 mg/100 ml] in 10 patients (6.5%). Important contributing factors were the preoperative severity of right heart failure (raised right atrial pressure at heart catheterisation) and hypotension or hypoxaemia and the amount of blood transfused during or shortly after surgery. Age, sex, underlying cardiac lesion, whether halothane was used, operative procedure, duration of cardiopulmonary bypass, and presence or absence of hepatitis B surface antigen were not predictive of postoperative jaundice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6695353      PMCID: PMC459721          DOI: 10.1136/thx.39.1.52

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  22 in total

1.  ACUTE PARENCHYMATOUS HEPATIC DISEASE FOLLOWING GENERAL ANESTHESIA: CLINICAL APPRAISAL OF HEPATOTOXICITY FOLLOWING ADMINISTRATION OF HALOTHANE.

Authors:  M H DYKES; S G WALZER; E M SLATER; J M GIBSON; D S ELLIS
Journal:  JAMA       Date:  1965-08-02       Impact factor: 56.272

2.  Halothane hepatitis as seen by the physician.

Authors:  W D Reed; R Williams
Journal:  Br J Anaesth       Date:  1972-09       Impact factor: 9.166

3.  A prospective study of changes in liver function after operation under two forms of general anaesthesia.

Authors:  M E Dodson; T G Richards
Journal:  Br J Anaesth       Date:  1972-01       Impact factor: 9.166

4.  Recurrent hepatitis attributable to halothane sensitization in an anesthetist.

Authors:  G Klatskin; D V Kimberg
Journal:  N Engl J Med       Date:  1969-03-06       Impact factor: 91.245

5.  Chronic hemolysis in patients with ball-valve prostheses.

Authors:  M N Andersen; E Gabrieli; J A Zizzi
Journal:  J Thorac Cardiovasc Surg       Date:  1965-10       Impact factor: 5.209

6.  Hepatic damage following profound hypothermia and extracorporeal circulation in man.

Authors:  D P Kingsley
Journal:  Thorax       Date:  1966-01       Impact factor: 9.139

7.  Jaundice following cardiopulmonary bypass.

Authors:  J S Robinson; F R Cole; P Gibson; J A Simpson
Journal:  Thorax       Date:  1967-05       Impact factor: 9.139

8.  Jaundice following open-heart surgery.

Authors:  R G Sanderson; J H Ellison; J A Benson; A Starr
Journal:  Ann Surg       Date:  1967-02       Impact factor: 12.969

9.  Progressive hepatic and renal failure associated with low cardiac output following open-heart surgery.

Authors:  E D Mundth; A R Keller; W G Austen
Journal:  J Thorac Cardiovasc Surg       Date:  1967-02       Impact factor: 5.209

10.  The incidence and causes of postoperative jaundice. A prospective study.

Authors:  C Evans; M Evans; A V Pollock
Journal:  Br J Anaesth       Date:  1974-07       Impact factor: 9.166

View more
  12 in total

1.  Jaundice after surgery for an aortic arch aneurysm.

Authors:  K Onoguchi; T Hachiya; T Sasaki; K Hashimoto; H Takakura; S Takeuchi
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-06

2.  Prediction of postoperative hepatic dysfunction after cardiac surgery in patients with chronic congestive heart failure.

Authors:  Hiroyuki Nishi; Toshiki Takahashi; Hajime Ichikawa; Goro Matsumiya; Hikaru Matsuda; Yoshiki Sawa
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-07-14

3.  Hyperbilirubinemia after extracorporeal circulation surgery: a recent and prospective study.

Authors:  Yong An; Ying-Bin Xiao; Qian-Jin Zhong
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

4.  Hepatic portal venous flow in patients undergoing tricuspid valve surgery.

Authors:  S F Purkiss; S Fort; T R Graham; P G Mills; C T Lewis
Journal:  Br Heart J       Date:  1994-04

5.  Preoperative assessment of congestive liver dysfunction using technetium-99 m galactosyl human serum albumin liver scintigraphy in patients with severe valvular heart disease.

Authors:  Hiroyuki Nishi; Toshiki Takahashi; Goro Matsumiya; Hiroshi Takano; Hajime Ichikawa; Shigeru Miyagawa; Yoshiki Sawa
Journal:  Surg Today       Date:  2007-06-26       Impact factor: 2.549

6.  Hyperbilirubinaemia after major thoracic surgery: comparison between open-heart surgery and oesophagectomy.

Authors:  K K Hosotsubo; M Nishimura; S Nishimura
Journal:  Crit Care       Date:  2000-03-27       Impact factor: 9.097

7.  Liver Function Tests Following Open Cardiac Surgery.

Authors:  Feridoun Sabzi; Reza Faraji
Journal:  J Cardiovasc Thorac Res       Date:  2015

8.  Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study.

Authors:  Xiaolan Chen; Ming Bai; Lijuan Zhao; Yangping Li; Yan Yu; Wei Zhang; Feng Ma; Shiren Sun; Xiangmei Chen
Journal:  J Cardiothorac Surg       Date:  2020-07-28       Impact factor: 1.637

9.  Hyperbilirubinaemia after cardiac surgery: the point of no return.

Authors:  Mina Farag; Gabor Veres; Gabor Szabó; Arjang Ruhparwar; Matthias Karck; Rawa Arif
Journal:  ESC Heart Fail       Date:  2019-05-16

10.  Time to peak bilirubin concentration and advanced AKI were associated with increased mortality in rheumatic heart valve replacement surgery patients with severe postoperative hyperbilirubinemia: a retrospective cohort study.

Authors:  Xiaolan Chen; Ming Bai; Lijuan Zhao; Yan Yu; Yuan Yue; Shiren Sun; Xiangmei Chen
Journal:  BMC Cardiovasc Disord       Date:  2021-01-06       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.